Effects of prolonged administration of d-penicillamine or captopril in various strains of rats: Brown Norway rats treated with d-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation

https://doi.org/10.1016/0090-1229(84)90015-1Get rights and content

Abstract

d-Penicillamine and captopril, two drugs that induce autoimmune manifestations in man, were administered orally for 5 to 10 months to various strains of rats. Three to eight weeks after d-penicillamine administration in a dosage of 20 to 50 mg per day, 73% of Brown Norway (BN) rats became ill. The disease was characterized by weight loss, dermatitis, and a high mortality presumably caused by disseminated intravascular coagulation. Microscopy revealed widespread granulomatous and necrotic lesions. The plasma of these animals contained antinuclear antibodies and immune complexes. In the kidney deposits of IgG were found in a linear pattern along the glomerular basement membrane. IgG eluted from diseased kidneys bound both “in vitro” and “in vivo” to kidney basement membranes. BN rats initially receiving 5 mg of d-penicillamine per day and subsequently 20 and 50 mg per day did not develop disease. No adverse effects were noted in Lewis (LEW) and Sprague-Dawley (SD) rats treated with 20 or 50 mg of d-penicillamine per day, nor in BN and LEW rats treated with 20 mg of captopril per day.

References (42)

  • D.B. Case et al.

    Prog. Cardiovasc. Dis.

    (1978)
  • H. Lis et al.
  • A.N. Theophilopoulos et al.

    J. Clin. Invest.

    (1976)
  • P.H. Lambert et al.

    J. Exp. Med.

    (1968)
  • E.R. Unanue et al.

    Ann. J. Pathol.

    (1973)
  • C.G. Cochrane et al.

    J. Exp. Med.

    (1973)
  • E.J.L. Prins
  • I.A. Jaffe

    Springer Semin. Immunopathol.

    (1981)
  • R.H. Heptinstall et al.

    Lancet

    (1982)
  • S.R. Batsford et al.

    Clin. Nephrol.

    (1976)
  • H.P. Seeling et al.

    Kidney Int.

    (1977)
  • K. Lange

    Contr. Nephrol.

    (1978)
  • Druet, P., and Morel Maroger, L. Unpublished...P. Druet et al.
  • A.A. Roman-Franco et al.

    Kidney Int.

    (1976)
  • L.A. Aarden et al.

    Ann. N.Y. Acad. Sci.

    (1975)
  • W.B. Rizzo et al.

    J. Biol. Chem.

    (1977)
  • P.G. McConahey et al.

    Int. Arch. Allergy Appl. Immunol.

    (1966)
  • J-M. Foidart et al.

    Lab. Invest.

    (1980)
  • P.H. Wooley et al.

    N. Engl. J. Med.

    (1980)
  • C. Sapin et al.

    Clin. Exp. Immunol.

    (1977)
  • J.J. Weening et al.

    Lab. Invest.

    (1978)
  • Cited by (77)

    • Idiosyncratic Adverse Drug Reactions

      2018, Comprehensive Toxicology: Third Edition
    • Animal Models of Idiosyncratic Drug Reactions

      2012, Advances in Pharmacology
      Citation Excerpt :

      It is interesting that penicillamine has been found to decrease ALT in patients being treated with the drug and this was ascribed to a hepatoprotective effect (Iorio et al., 2004; Gong et al., 2006); however, it is likely that much of the effect actually involved interference with the ALT assay. In animal studies, it was found that the liver is involved in penicillamine-induced autoimmunity (Donker et al., 1984). Granulomatous and necrotic lesions were observed in the rats that developed penicillamine-induced autoimmunity.

    • Chemically Induced Allergy and Autoimmunity

      2010, Comprehensive Toxicology, Second Edition
    View all citing articles on Scopus

    Part of this study was presented at the Annual Meeting of the American Society of Nephrology, Washington, D.C., 1981.

    2

    Recipient of a Bertha and Henry Buswell Research Fellowship, School of Medicine, State University of New York, Buffalo, N.Y.

    View full text